NVO
Novo Nordisk A/S
NYSE · Healthcare · Drug Manufacturers - General · DK
$46.60
−1.92%Institutional positioning
13F filings over the trailing two quarters
New 369Increased 919Reduced 962Sold out 127
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 31,024,311 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 25,655,076 | Aug 14, 2026 |
| DODGE & COX | Increased | 20,397,110 | Aug 13, 2026 |
| CITADEL ADVISORS LLC | Reduced | 20,139,625 | May 15, 2026 |
| DODGE & COX | New Position | 19,333,750 | May 14, 2026 |
| CITADEL ADVISORS LLC | Reduced | 19,257,075 | Sep 2, 2026 |
| LOOMIS SAYLES & CO L P | Increased | 18,594,352 | Aug 14, 2026 |
| LOOMIS SAYLES & CO L P | Reduced | 17,017,315 | May 14, 2026 |
| FRANKLIN RESOURCES INC | Increased | 16,083,479 | May 13, 2026 |
| FRANKLIN RESOURCES INC | Reduced | 13,041,109 | Aug 13, 2026 |
| JANE STREET GROUP, LLC | Reduced | 12,881,307 | May 12, 2026 |
| CAPITAL INTERNATIONAL INVESTORS | Increased | 11,795,850 | May 13, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 11,790,290 | Aug 14, 2026 |
| JANE STREET GROUP, LLC | Reduced | 11,723,200 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 11,704,719 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings